课题基金 / 基金详情

Reactive oxygen species and diabetic nephropathy

Reactive oxygen species and diabetic nephropathy
活性氧与糖尿病肾病
批准号:
14370319
负责人:
MAKINO Hirofumi
金额:
$5.82万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

MAKINO Hirofumi的其他基金

相似基金

相关文献

中文摘要
翻译
高血糖诱导的线粒体活性氧簇(ROS)的过量产生已成为糖尿病血管并发症的主要因素。哺乳动物线粒体内膜转位酶44(Tim44)在糖尿病小鼠肾脏中表达上调。Tim44作为mtHsp70到TIM23复合体的膜锚,参与了线粒体靶向前蛋白进入线粒体基质的过程。这一过程依赖于线粒体Hsp70的内膜电位(Δψ)和ATPase结构域上的三磷酸腺苷的降解。以日本血凝病毒(HVJ)为载体,经尾静脉注入链脲佐菌素(STZ)诱导的糖尿病小鼠CD-1模型,每周一次尾静脉注射日本血凝病毒(HVJ)-囊膜载体pcDNA3.1。注射后8周,基因载体可减轻蛋白尿和肾脏肥大,抑制肾细胞增殖和凋亡,抑制超氧化物生成。用人近端肾小管(HK2)细胞进行的体外实验表明,Tim44的基因传递逆转了高糖诱导的代谢和细胞异常,如ROS产生增加,ATP含量增加,内膜电位改变,细胞增殖和凋亡增加。通过siRNA和表达载体Tim44的表达,发现Tim44能促进超氧化物歧化酶和谷胱甘肽过氧化物酶等抗氧化酶进入线粒体。因此,Tim44的基因传递似乎有利于维持线粒体的功能,是糖尿病肾病的一种新的治疗方法。
英文摘要
Hyperglycemia-induced overproduction of mitochondrial reactive oxygen species (ROS) has emerged as a major player in diabetic vascular complications. Mammalian translocase of inner mitochondrial membrane 44 (Tim44) was identified by up-regulation in diabetic mouse kidneys. Tim44 functions as a membrane anchor of mtHsp70 to TIM23 complex and involves in the import of mitochondria-targeted preproteins into mitochondrial matrix. The process is dependent on inner membrane potential (Δψ) and ATP hydrolysis on ATPase domain of mtHsp70. Hemagglutination virus of Japan (HVJ)-envelope vector carrying pcDNA3.1 plasmid containing the full length cDNA of Tim44 and control plasmid were weekly injected from tail vein into uninephrectomized streptozotocin-induced diabetic CD-1 mice. The gene delivery alleviated proteinuria and renal hypertrophy at 8 weeks after the injection and inhibited renal cell proliferation and apoptosis, and suppressed superoxide production. In vitro experiments, using human proximal tubular (HK2) cells, revealed that the gene delivery of Tim44 reversed high glucose induced metabolic and cellular abnormalities such as, enhanced ROS production, increased ATP contents, alterations in inner membrane potential, increased cell proliferation and apoptosis. Transfection with siRNA and expressing vector of Tim44 revealed that Tim44 facilitates import of anti-oxidative enzymes such as superoxide dismutase (SOD) and glutathione peroxidase into mitochondria. The gene delivery of Tim44 thus seems to be beneficial for the maintenance of mitochondrial function and is a novel therapeutic approach for diabetic nephropathy.
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
Okada S et al.: "Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes."Diabetes. 52. 2586-2593 (2003)
Okada S 等人:“细胞间粘附分子 1 缺陷的小鼠在诱导糖尿病后能够抵抗肾损伤。”糖尿病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
糖尿病性腎症 糖尿病合併症の診かた・考え方
糖尿病肾病 如何诊断和思考糖尿病并发症
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: [岡田達夫, 和田淳, 槇野博史]
通讯作者: 槇野博史
Elevated serum MCP-4 levels in overweight subjects and its correlation with chronic inflammation.
超重受试者血清 MCP-4 水平升高及其与慢性炎症的相关性。
DOI: --
发表时间: 2006
期刊: Obes Res 14(5)
影响因子: --
作者: [Hashimoto I, Wada J, Hida A, Baba M, Miyatake N, Eguchi J, Shikata K, Makino H]
通讯作者: Makino H
Update of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephroqenesis.
哺乳动物肾病中细胞外基质、其受体和细胞粘附分子的更新。
DOI: --
发表时间: 2004
期刊: Am J Physiol Renal Physiol 286(2)
影响因子: --
作者: [Kanwar YS, Wada J et al.]
通讯作者: Wada J et al.
共 24 条
    Nuclear receptors as therapeutic targets for diabeticnephropathy.
    • 批准号:
      21249053
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.12万
    • 财政年份:
      2009
    • 负责人:
      MAKINO Hirofumi
    • 依托单位:
    New therapeutic approach to diabetic nephropathy by modulating mitochondrial function
    • 批准号:
      18390249
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.0万
    • 财政年份:
      2006
    • 负责人:
      MAKINO Hirofumi
    • 依托单位:
    Molecular mechanism of glomerular hyperfiltration in diabetic nephropathy revealed by gene expression profiling.
    • 批准号:
      11470218
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.56万
    • 财政年份:
      1999
    • 负责人:
      MAKINO Hirofumi
    • 依托单位:
    Application of anti-cell adhesion molecule therapies for renal diseases.
    • 批准号:
      08671287
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1996
    • 负责人:
      MAKINO Hirofumi
    • 依托单位:
    国内基金
    海外基金
    SIRT3/FoxO3a/ROS通路介导的铁死亡在脓毒症肌肉萎缩中的作用及机制研究
    • 批准号:
      2026JJ30096
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谢鹏
    • 依托单位:
    基于巨噬细胞MPO缺失的线粒体ROS/KLF4通路对动脉粥样硬化斑块不稳定性的机制研究
    • 批准号:
      2026JJ82110
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      黄江伟
    • 依托单位:
    双功能COFs基S型异质结的精准构建及其光催化产H2O2驱动ROS级联杀菌的机制研究
    • 批准号:
      2026JJ80004
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      张淑敏
    • 依托单位: